Evidence map›Paper›PMID 32870407›Full record

ReviewCurrent urology reports2020

What Should Be Known by a Urologist About the Medical Management of COVID-19's Patients?

Álvaro Sánchez-González, Luis López-Fando Lavalle, Alberto Esteban-Fernández, Mercedes Ruiz, Vital Hevia, Belén Comeche, Matilde Sánchez Conde, Sara Álvarez, Javier Lorca Álvaro, Agustín Fraile Poblador and 8 more

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current urology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Álvaro Sánchez-GonzálezUrology Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Luis López-Fando LavalleUrology Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain. llfando@gmail.com.
Alberto Esteban-FernándezCardiology Service, Severo Ochoa University Hospital, Rey Juan Carlos University, Leganés (Madrid), Spain.
Mercedes RuizUrology Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Vital HeviaUrology Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Belén ComecheInfectious Diseases Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Matilde Sánchez CondeInfectious Diseases Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Sara ÁlvarezUrology Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Javier Lorca ÁlvaroUrology Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Agustín Fraile PobladorUrology Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Manuel Hevia PalaciosUrology Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Ana Domínguez GutiérrezUrology Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Alberto Artiles MedinaUrology Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Enrique Sanz MayayoUrology Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Gemma DuqueUrology Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Victoria Gómez Dos SantosUrology Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Santiago Moreno-GuillénInfectious Diseases Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Javier Burgos RevillaUrology Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain.
Instituto Cajal · ESInstituto Ramón y Cajal de Investigación Sanitaria · ESUniversidad de Alcalá · ESHospital Universitario Severo Ochoa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThe alarming number of confirmed COVID-19 cases put a strain on the healthcare systems, which had to reallocate human and technical resources to respond to the emergency. Many urologists became integrated into multidisciplinary teams, dealing with this respiratory illness and its unknown management. It aims to summarize the epidemiological, clinical, diagnostical, and therapeutical characteristics of COVID-19, from a practical perspective, to ease COVID-19 management to non-physician staff. RECENT

findingsWe performed a narrative review of the literature regarding COVID-19, updated to May 8th, 2020, at PubMed and COVID resource platforms of the main scientific editorials. COVID-19, characterized by fever, myalgias, dyspnea, and dry cough, varies widely from asymptomatic infection to death. Arrhythmias and thrombotic events are prevalent. Lymphopenia and inflammatory reactant elevation on laboratory, as well as bilateral and peripheral ground-glass opacities or consolidations on X-Ray, are usually found in its assessment. Little is known about SARS-CoV-2 immunology. To date, no therapy has demonstrated efficacy in COVID-19. Of-level or compassionate-use therapies are prescribed in the context of clinical trials. We should become familiar with specific adverse events and pharmacological interactions. The COVID-19 pandemic has paralyzed the urological activity, and its long-term consequences are unpredictable. Despite not being used to deal with respiratory diseases, the urologists become easily qualified to manage COVID-19 by following protocols and being integrated into multidisciplinary teams, helping to overcome the pandemic.

Indexed as

UrologyBetacoronavirusCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralSARS-CoV-2COVID-19Medical managementReviewSARS-CoV-2TreatmentUrologist

Identifiers

PMID32870407
PMCPMC7459251
OpenAlexW3082405812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.